Gebbia Vittorio, Carnaghi Carlo
Department of Medical Oncology, Faculty of Medicine, University of Enna "Kore", Enna 94100, Italy.
Medical Oncology Unit, Cdc Torina, Palermo 90145, Italy.
World J Clin Cases. 2024 Jun 26;12(18):3291-3294. doi: 10.12998/wjcc.v12.i18.3291.
Primary or secondary clear cell sarcoma of the pancreas is an exceedingly rare and aggressive disease. In addition to pathology, molecular analysis is pivotal in differential diagnosis, especially with malignant melanoma. A key aspect in identifying clear cell sarcoma is specific genetic alterations, notably the translocation of t(12;22) (q13;q13), a diagnostic hallmark of this sarcoma subtype, which is absent in malignant melanoma. Treatment of primary clear cell sarcoma of the pancreas is the same as that for adenocarcinoma.
胰腺原发性或继发性透明细胞肉瘤是一种极其罕见且侵袭性强的疾病。除病理学外,分子分析在鉴别诊断中至关重要,尤其是与恶性黑色素瘤的鉴别。识别透明细胞肉瘤的一个关键方面是特定的基因改变,特别是t(12;22)(q13;q13)易位,这是该肉瘤亚型的诊断标志,而在恶性黑色素瘤中不存在。胰腺原发性透明细胞肉瘤的治疗与腺癌相同。